Neutralizing antibodies have a higher affinity to interferon-beta than non-neutralizing antibodies

被引：0
|
作者：
Tripp, P [1 ]
Gneiss, C [1 ]
Deisenhammer, F [1 ]
机构：
[1] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2004年 / 154卷 / 1-2期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
721
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [41] Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis
    Manceau, Philippe
    latarche, ClotilDe
    Pittion, Sophie
    Edan, Gilles
    de Seze, Jerome
    Massart, Catherine
    Debouverie, Marc
    BMC NEUROLOGY, 2014, 14
  • [42] Neutralizing anti-interferon beta antibodies are associated with reduced side effects and delayed impact on efficacy of Interferon-beta
    Farrell, R.
    Kapoor, R.
    Leary, S.
    Rudge, P.
    Thompson, A. J.
    Millerand, D. H.
    Giovannoni, G.
    MULTIPLE SCLEROSIS, 2008, 14 (02): : 212 - 218
  • [43] High dose intravenous interferon-beta in MS patients with neutralizing antibodies (HINABS) - A pilot study
    Deisenhammer, Florian
    Millonig, Alban
    Gneiss, Claudia
    Reindl, Markus
    Berger, Thomas
    NEUROLOGY, 2008, 70 (11) : A272 - A273
  • [44] Inhibition of Endogenous Interferon Beta by Neutralizing Antibodies Against Recombinant Interferon Beta
    Sominanda, Ajith
    Lundkvist, Malin
    Fogdell-Hahn, Anna
    Hemmer, Bernhard
    Hartung, Hans-Peter
    Hillert, Jan
    Menge, Til
    Kieseier, Bernd C.
    ARCHIVES OF NEUROLOGY, 2010, 67 (09) : 1095 - 1101
  • [45] Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
    Izadi, Arman
    Nordenfelt, Pontus
    TRENDS IN IMMUNOLOGY, 2024, 45 (08) : 609 - 624
  • [46] THE CHARACTERIZATION OF NEUTRALIZING AND NON-NEUTRALIZING MONOCLONAL-ANTIBODIES AGAINST EQUID HERPESVIRUS TYPE-1
    SINCLAIR, R
    COOK, RF
    MUMFORD, JA
    JOURNAL OF GENERAL VIROLOGY, 1989, 70 : 455 - 459
  • [47] Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samples
    Cludts, Isabelle
    Meager, Anthony
    Thorpe, Robin
    Wadhwa, Meenu
    JOURNAL OF IMMUNOLOGICAL METHODS, 2013, 395 (1-2) : 37 - 44
  • [48] The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
    Earnest, James T.
    Holmes, Autumn C.
    Basore, Katherine
    Mack, Matthias
    Fremont, Daved H.
    Diamond, Michael S.
    CELL REPORTS, 2021, 35 (01):
  • [49] The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A
    Oomen, Ilja
    Verhagen, Marieke
    Miranda, Mariarosaria
    Allacher, Peter
    Beckers, Erik A. M.
    Blijlevens, Nicole M. A.
    van der Bom, Johanna G.
    Coppens, Michiel
    Driessens, Mariette
    Eikenboom, Jeroen C. J.
    Fijnvandraat, Karin
    Hassan, Shermarke
    van Heerde, Waander L.
    Hooimeijer, H. Louise
    Jansen, Joop H.
    Kaijen, Paul
    Leebeek, Frank W. G.
    Meijer, Danielle
    Paul, Helmut
    Rijpma, Sanna R.
    Rosendaal, Frits R.
    Smit, Cees
    van Vulpen, Lize F. D.
    Voorberg, Jan
    Schols, Saskia E. M.
    Gouw, Samantha C.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [50] The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis
    Koch-Henriksen, N.
    Sorensen, P. S.
    Bendtzen, K.
    Flachs, E. M.
    MULTIPLE SCLEROSIS, 2009, 15 (05): : 601 - 605
12345